🇺🇸 FDA

Intelligence Platform

Patents

Browse 454 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7358247

Mycophenolate mofetil impurity

TEVA Gyógyszergyár Zártkörüen Müködö Részvénytárasaság · Granted Tue Apr 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7357945

Stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparatio

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Apr 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7355078

Processes for the preparation of tomoxetine

Teva Pharmaceutical Fine Chemicals S.R.L. · Granted Tue Apr 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7348429

Process for purifying N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide(

TEVA Gyógyszergyár Zártkörüen Müködö Részvénytárasaság · Granted Tue Mar 25 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7342120

Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 11 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 06 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7335772

1H-imidazo [4,5-c] quinolin-4-cyano and 1H-imidazo [4,5-c] quinolin-4-carboxamide intermed

TEVA Gyógyszergyár Zártkörüen Müködö Részvénytárasaság · Granted Tue Feb 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7335685

Crystals of ladostigil tartrate, methods of production and pharmaceutical compositions the

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Feb 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7332612

Amorphous and crystalline forms of losartan potassium and process for their preparation

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Feb 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7323459

Crystal forms, methods for their preparation and method for preparation of olanzapine

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jan 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7319171

Sertraline hydrochloride form II and methods for the preparation thereof

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jan 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7317127

Process for the optical resolution and recycling of tomoxetine

Teva Pharmaceutical Fine Chemicals S.R.L. · Granted Tue Jan 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7312340

Synthesis of 2-butyl-3-(1-trityl-1H-tetrazol-5-YL)biphenyl-4-YL)-1,3-diazaspiro[4,4]- non-

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Dec 25 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 20 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7301024

Crystalline forms of gatifloxacin and processes for preparation

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Nov 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7294735

Purification of cinacalcet

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Nov 13 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7294687

Parenteral formulations of a peptide for the treatment of systemic lupus erythematosus

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Nov 13 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7291614

Processes for the preparation of linezolid intermediate

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Nov 06 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7279571

Methods of preparing pimecrolimus

TEVA Gyógyszergyár Zártkörüen Müködö Részvénytárasaság · Granted Tue Oct 09 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 04 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7276629

Hydrogenation of imine intermediates of sertraline with catalysts

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Oct 02 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7262218

Forms of pravastatin sodium

TEVA GYOGYSZERGYAR ZARTKORUEN MUKODO RESZVENYTARSASAG · Granted Tue Aug 28 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 23 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7259261

Racemization and enantiomer separation of clopidogrel

TEVA Gyógyszergyár Zártkörüen Müködö Részvénytárasaság · Granted Tue Aug 21 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 16 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7256195

Preparation of risperidone

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Aug 14 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 09 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7256212

Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Aug 14 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 09 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7247751

Processes for preparing cinacalcet hydrochloride crystal Form I

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jul 24 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7244844

Reference standard for characterization of rosuvastatin

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jul 17 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted